Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
- DOI
- 10.1038/s41467-026-73126-9
- Published
- 2026-06-04
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-73126-9,
title = {Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy},
author = {Mitchell J. Elliott and Jesús Fuentes-Antrás and Sasha C. Main and Aaron Dou and Elizabeth Shah and Caroline Weipert and Geethika Yalamanchili and Taylor Bird and June Roh and Celeste Yu and Michelle B. Nadler and Eitan Amir and Hal K. Berman and Lillian L. Siu and Philippe L. Bedard and David W. Cescon},
year = {2026},
journal = {Nature Communications},
doi = {10.1038/s41467-026-73126-9},
url = {https://doi.org/10.1038/s41467-026-73126-9}
}RIS
TY - JOUR TI - Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy AU - Mitchell J. Elliott AU - Jesús Fuentes-Antrás AU - Sasha C. Main AU - Aaron Dou AU - Elizabeth Shah AU - Caroline Weipert AU - Geethika Yalamanchili AU - Taylor Bird AU - June Roh AU - Celeste Yu AU - Michelle B. Nadler AU - Eitan Amir AU - Hal K. Berman AU - Lillian L. Siu AU - Philippe L. Bedard AU - David W. Cescon PY - 2026 JO - Nature Communications DO - 10.1038/s41467-026-73126-9 UR - https://doi.org/10.1038/s41467-026-73126-9 ER -
APA
Elliott, M. J., Fuentes-Antrás, J., Main, S. C., Dou, A., Shah, E., Weipert, C., Yalamanchili, G., Bird, T., Roh, J., Yu, C., Nadler, M. B., Amir, E., Berman, H. K., Siu, L. L., Bedard, P. L., & Cescon, D. W. (2026). Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy. Nature Communications. https://doi.org/10.1038/s41467-026-73126-9
Source records
- crossref · retrieved 2026-09-26T07:01:13.805Z